Safety and efficacy of bevacizumab plus chemotherapy as first-line treatment of patients with metastatic colorectal cancer: Updated results from a large observational registry in the US (BRiTE)

被引:0
|
作者
Kozloff, M.
Hainsworth, J.
Badrinath, S.
Cohn, A.
Flynn, P.
Steis, R.
Dong, W.
Suzuki, S.
Sarkar, S.
Sugrue, M.
Grothey, A.
机构
[1] Mayo Clin, Rochester, MN USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] Atlanta Canc Care, Roswell, GA USA
[4] Abbott NW Hosp, Minneapolis, MN USA
[5] Rocky Mt Canc Ctr, Denver, CO USA
[6] Florida Oncol Associates, Jacksonville, FL USA
[7] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[8] Univ Chicago, Chicago, IL 60637 USA
[9] Ingalls Hosp, Harvey, IL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:24 / 24
页数:1
相关论文
共 50 条
  • [1] Safety and efficacy of bevacizumab plus chemotherapy as first-line treatment of patients with metastatic colorectal cancer: Updated results from a large observational registry in the US (BRITE)
    Kozloff, M.
    Hainsworth, J.
    Badarinath, S.
    Cohn, A.
    Flynn, P.
    Steis, R.
    Dong, W.
    Suzuki, S.
    Sugrue, M.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2006, 17 : 128 - 128
  • [2] Safety of bevacizumab plus chemotherapy as first-line treatment of patients with metastatic colorectal cancer: Updated results from a large observational registry in the US (BRiTE).
    Hedrick, E.
    Kozloff, M.
    Hainsworth, J.
    Badarinath, S.
    Cohn, A.
    Flynn, P.
    Dong, W.
    Suzuki, S.
    Sugrue, M.
    Grothey, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 155S - 155S
  • [3] Safety analysis of first-line bevacizumab plus chemotherapy in patients with metastatic colorectal cancer (mCRC) participating in a US registry
    Kozloff, M.
    Cohn, A.
    Christiansen, N.
    Flynn, P.
    Kabbinavar, F.
    Robles, R.
    Ulcickas-Yood, M.
    Sarkar, S.
    Hambleton, J.
    Grothey, A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 173 - 173
  • [4] SAFETY AND EFFICACY OF BEVACIZUMAB PLUS STANDARD FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER: FIRST BEAT
    Van Cutsem, E.
    Berry, S.
    Michael, M.
    Kretzschmar, A.
    Rivera, F.
    DiBartolomeo, M.
    Mazier, M.
    Andre, N.
    Cunningham, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 125 - 125
  • [5] SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER: UPDATED RESULTS FROM A LARGE CZECH OBSERVATIONAL REGISTRY
    Prausova, J.
    Gruna, J.
    Twardzikova, P.
    Vyzula, R.
    Benesova, V
    Bartos, J.
    Sejdova, M.
    Petera, J.
    Ostrizkova, L.
    Finek, J.
    ANNALS OF ONCOLOGY, 2009, 20 : 71 - 72
  • [6] Efficacy and safety of first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a meta-analysis
    Wang Ming
    Zheng Xiaofeng
    Ruan Xiaojiao
    Ye Bailiang
    Cai Long
    Lin Feizhuan
    Tu Jinfu
    Jiang Feizhao
    Li Shaotang
    CHINESE MEDICAL JOURNAL, 2014, 127 (03) : 538 - 546
  • [7] Optimizing the Efficacy of First-Line Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer
    Shaotang Li
    Pan Dr Chi
    BioDrugs, 2011, 25 : 43 - 50
  • [8] FIRST-LINE TREATMENT WITH BEVACIZUMAB PLUS CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER: RESULTS FROM A LARGE GERMAN COMMUNITY-BASED OBSERVATIONAL COHORT STUDY
    Arnold, D.
    Kindler, M.
    Petersen, V
    Tummes, D.
    Molle, M.
    Schoberl, C.
    Srock, S.
    Kutscheidt, A.
    Grothe, W.
    ANNALS OF ONCOLOGY, 2010, 21 : 21 - 21
  • [9] Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: results from a large community-based observational cohort study in Germany
    Arnold, D.
    Kindler, M.
    Petersen, V.
    Tummes, D.
    Moelle, M.
    Schoeberl, C.
    Srock, S.
    Hinke, A.
    Grothe, W.
    ONKOLOGIE, 2010, 33 : 61 - 61
  • [10] Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer
    Bai, Long
    Wang, Feng
    Li, Zhe-zhen
    Ren, Chao
    Zhang, Dong-sheng
    Zhao, Qi
    Lu, Yun-xin
    Wang, De-shen
    Ju, Huai-qiang
    Qiu, Miao-zhen
    Wang, Zhi-qiang
    Wang, Feng-hua
    Xu, Rui-hua
    MEDICINE, 2016, 95 (51) : e4531